Indaptus Therapeutics (INDP) Assets Average (2021 - 2026)
Indaptus Therapeutics (INDP) posted quarterly Assets Average of $5.7 million for Q1 2026, down 9.88% year-over-year from $6.4 million in Q1 2025, and down 28.85% quarter-over-quarter from $8.1 million in Q4 2025.
Indaptus Therapeutics (INDP) Assets Average (2021 - 2026) Analysis & Trends
Indaptus Therapeutics' Assets Average history runs 6 years deep, the most recent figure standing at $5.7 million for Q1 2026.
- In Q1 2026, Assets Average fell 9.88% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (down 9.88% YoY), while the FY2025 annual figure was $8.3 million, down 25.22% from the prior year.
- Assets Average for Q1 2026 stood at $5.7 million, down from $8.1 million in the prior quarter.
- The five-year high for Assets Average was $38.8 million in Q1 2022, with the low at $5.7 million in Q1 2026.
- The 5-year median for Assets Average is $12.9 million (2024), against an average of $17.1 million.
- The sharpest annual moves came in 2022 and 2024: Assets Average surged 304.33% in 2022, then sank 57.65% in 2024.
- Indaptus Therapeutics' Assets Average stood at $29.3 million in 2022, then plunged by 44.09% to $16.4 million in 2023, then plunged by 52.39% to $7.8 million in 2024, then rose by 3.67% to $8.1 million in 2025, then slipped by 28.85% to $5.7 million in 2026.
- Business Quant data shows INDP's Assets Average at $5.7 million in Q1 2026, $8.1 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | 7.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.08 Mn |
| Mar 31, 2026 | 5.75 Mn |
| Dec 31, 2025 | 8.08 Mn |
| Sep 30, 2025 | 6.84 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 7.79 Mn |
| Sep 30, 2024 | 8.18 Mn |
| Jun 30, 2024 | 9.54 Mn |
| Mar 31, 2024 | 12.94 Mn |
| Dec 31, 2023 | 16.36 Mn |
| Sep 30, 2023 | 19.32 Mn |
| Jun 30, 2023 | 21.99 Mn |
| Mar 31, 2023 | 25.60 Mn |
| Dec 31, 2022 | 29.26 Mn |
| Sep 30, 2022 | 32.26 Mn |
| Jun 30, 2022 | 35.57 Mn |
| Mar 31, 2022 | 38.83 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Sep 30, 2021 | 31.98 Mn |